No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| AIZAssurant, Inc. | 11.89B | 237.45 | 16.42 | 6.7% | 6.75% | 14.74% | 9.35% | 0.41 |
| JRVRJames River Group Holdings, Ltd. | 307.51M | 6.69 | -2.19 | -12.85% | -7.64% | -7.76% | 0.51 | |
| HIPOHippo Holdings Inc. | 773.74M | 30.54 | -18.62 | 77.44% | 21.31% | 22.75% | 6.1% | 0.03 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.31B | 7.11B | 6.31B | 8B | 9.53B | 9.61B | 10.19B | 10.19B | 11.13B | 11.88B |
| Revenue Growth % | -0.01% | -0.31% | -0.11% | 0.27% | 0.19% | 0.01% | 0.06% | 0% | 0.09% | 0.07% |
| Medical Costs & Claims | 0 | 0 | 3.21B | 4.64B | 5.62B | 5.95B | 6.04B | 2.36B | 2.52B | 2.77B |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 10.31B | 7.11B | 3.1B | 3.36B | 3.91B | 3.66B | 4.15B | 7.83B | 8.61B | 9.11B |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 1.3% | -0.31% | -0.56% | 0.08% | 0.16% | -0.06% | 0.13% | 0.89% | 0.1% | 0.06% |
| Operating Expenses | 10.12B | 6.68B | 2.66B | 3.02B | 3.45B | 3.09B | 3.38B | 7.48B | 7.8B | 8.18B |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 137.1M | 86.49M | 115.7M | 126.9M | 125.5M | 142.3M | 171.6M | 182M | 196.4M | 223.5M |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 256.3M | 906.21M | 444.5M | 333.5M | 454.7M | 578.1M | 771.3M | 349.9M | 806.8M | 927.3M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -0.66% | 2.54% | -0.51% | -0.25% | 0.36% | 0.27% | 0.33% | -0.55% | 1.31% | 0.15% |
| EBITDA | 393.4M | 992.7M | 560.2M | 460.4M | 580.2M | 720.4M | 942.9M | 531.9M | 1B | 1.15B |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 55.12M | 57.62M | 49.5M | 100.3M | 110.6M | 104.5M | 111.8M | 108.3M | 108M | 107M |
| Non-Operating Income | -256.3M | -906.2M | -49.5M | -100.3M | -110.6M | -104.5M | -111.8M | -108.3M | -108M | -107M |
| Pretax Income | 201.18M | 848.59M | 444.5M | 333.5M | 454.7M | 578.1M | 771.3M | 349.9M | 806.8M | 927.3M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 59.63M | 283.24M | -75.1M | 80.9M | 148.3M | 58.7M | 168.4M | 73.3M | 164.3M | 167.1M |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 141.56M | 565.35M | 519.6M | 251M | 382.6M | 440.8M | 1.36B | 276.6M | 642.5M | 760.2M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -0.7% | 2.99% | -0.08% | -0.52% | 0.52% | 0.15% | 2.09% | -0.8% | 1.32% | 0.18% |
| EPS (Diluted) | 2.05 | 9.13 | 9.39 | 4.22 | 6.14 | 6.70 | 10.20 | 5.05 | 11.95 | 14.46 |
| EPS Growth % | -0.68% | 3.45% | 0.03% | -0.55% | 0.45% | 0.09% | 0.52% | -0.5% | 1.37% | 0.21% |
| EPS (Basic) | 2.08 | 9.23 | 9.45 | 4.24 | 6.18 | 7.04 | 10.37 | 5.09 | 12.02 | 14.55 |
| Diluted Shares Outstanding | 69.02M | 61.93M | 55.31M | 59.55M | 62.31M | 63.18M | 60.12M | 54.78M | 53.78M | 52.58M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 30.08B | 29.71B | 31.84B | 41.09B | 44.29B | 44.65B | 33.92B | 33.12B | 33.64B | 35.02B |
| Asset Growth % | -0.05% | -0.01% | 0.07% | 0.29% | 0.08% | 0.01% | -0.24% | -0.02% | 0.02% | 0.04% |
| Total Investment Assets | 14.32B | 12.51B | 13.3B | 16.34B | 16.59B | 8.22B | 8.67B | 7.52B | 8.22B | 8.54B |
| Long-Term Investments | 11.22B | 10.22B | 746.5M | 1.69B | 15.13B | 7.4B | 7.91B | 6.72B | 7.39B | 7.67B |
| Short-Term Investments | 10.72B | 9.8B | 9.95B | 11.63B | 12.72B | 7.11B | 7.46B | 6.44B | 2.11B | 2.38B |
| Total Current Assets | 2.55B | 2.25B | 2.23B | 2.9B | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 1.29B | 1.03B | 996.8M | 1.25B | 1.87B | 2.21B | 2.04B | 1.54B | 1.63B | 1.81B |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 0 | 0 | -25.88B | -17.47B | -17.63B | -17.38B | -12.65B | -13.82B |
| Goodwill & Intangibles | 1.15B | 1.1B | 1.23B | 5.48B | 4.89B | 4.44B | 3.87B | 3.5B | 3.26B | 3.16B |
| Goodwill | 833.51M | 830.9M | 917.7M | 2.32B | 2.34B | 2.59B | 2.57B | 2.6B | 2.61B | 2.62B |
| Intangible Assets | 318.32M | 272.4M | 313M | 3.16B | 2.54B | 1.85B | 1.3B | 901.7M | 651M | 543.6M |
| PP&E (Net) | 298.41M | 343.57M | 347.6M | 392.5M | 433.7M | 446.1M | 561.4M | 645.1M | 685.8M | 768.3M |
| Other Assets | 11.91B | 15.98B | 17.25B | 18.63B | -20.46B | -12.28B | -12.34B | -10.87B | -11.34B | -11.59B |
| Total Liabilities | 25.55B | 25.61B | 27.56B | 35.96B | 38.61B | 38.7B | 28.46B | 28.89B | 28.83B | 29.91B |
| Total Debt | 1.17B | 1.07B | 1.07B | 2.01B | 2.01B | 2.25B | 2.2B | 2.13B | 2.08B | 2.08B |
| Net Debt | -116.92M | 35.05M | 71.4M | 752M | 139.8M | 45.3M | 161.7M | 593.2M | 453M | 275.4M |
| Long-Term Debt | 1.16B | 1.07B | 1.07B | 2.01B | 2.01B | 2.25B | 2.2B | 1.91B | 2.08B | 2.08B |
| Short-Term Debt | 0 | 48.06M | 393.7M | 105.5M | 0 | 0 | 0 | 224.7M | 0 | 0 |
| Total Current Liabilities | 24.35B | 24.54B | 26.5B | 33.97B | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 4.03B | 3.4B | 3.93B | 3.14B | 3.05B | 1.97B | 2.05B | 2.7B | 2.42B | 3.41B |
| Deferred Revenue | 0 | -48.06M | -393.7M | -105.5M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.66B | 1.06B | 957.8M | 1.33B | -3.59B | -2.67B | -2.74B | -3.58B | -2.96B | -3.97B |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 24.35B | 0 | 26.49B | 0 | -2.01B | -2.25B | -2.2B | -1.91B | -2.08B | -2.08B |
| Total Equity | 4.52B | 4.1B | 4.28B | 5.13B | 5.68B | 5.95B | 5.46B | 4.23B | 4.81B | 5.11B |
| Equity Growth % | -0.13% | -0.09% | 0.04% | 0.2% | 0.11% | 0.05% | -0.08% | -0.23% | 0.14% | 0.06% |
| Shareholders Equity | 4.52B | 4.1B | 4.27B | 5.11B | 5.65B | 5.95B | 5.46B | 4.23B | 4.81B | 5.11B |
| Minority Interest | 0 | 0 | 10.9M | 21.9M | 29.3M | 3.4M | 0 | 0 | 0 | 0 |
| Retained Earnings | 4.41B | 4B | 4.04B | 5.76B | 5.97B | 3.55B | 4.04B | 3.7B | 4.03B | 4.38B |
| Common Stock | 1.5M | 1.5M | 1.5M | 1.6M | 1.6M | 600K | 700K | 600K | 600K | 500K |
| Accumulated OCI | 118.55M | 94.6M | 234M | -155.4M | 411.5M | 709.8M | -150M | -986.2M | -765M | -836.1M |
| Return on Equity (ROE) | 0.03% | 0.13% | 0.12% | 0.05% | 0.07% | 0.08% | 0.24% | 0.06% | 0.14% | 0.15% |
| Return on Assets (ROA) | 0% | 0.02% | 0.02% | 0.01% | 0.01% | 0.01% | 0.03% | 0.01% | 0.02% | 0.02% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | 0.26x | 0.26x | 0.25x | 0.39x | 0.35x | 0.38x | 0.40x | 0.50x | 0.43x | 0.41x |
| Book Value per Share | 65.55 | 66.17 | 77.41 | 86.22 | 91.19 | 94.25 | 90.88 | 77.19 | 89.42 | 97.12 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 254.57M | 134.53M | 530.4M | 656.7M | 1.41B | 1.34B | 781.7M | 596.9M | 1.14B | 1.33B |
| Operating CF Growth % | -0.35% | -0.47% | 2.94% | 0.24% | 1.15% | -0.05% | -0.42% | -0.24% | 0.91% | 0.17% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 141.56M | 565.35M | 519.6M | 251M | 382.6M | 441.8M | 1.37B | 276.6M | 642.5M | 760.2M |
| Depreciation & Amortization | 137.1M | 125.14M | 115.7M | 126.9M | 125.8M | 144.3M | 171.6M | 182M | 196.4M | 223.5M |
| Stock-Based Compensation | 38.77M | 41.61M | 35.5M | 57.1M | 55.9M | 57.9M | 66.7M | 62.6M | 75.1M | 81.1M |
| Deferred Taxes | 88.66M | -182.89M | -4.2M | 20.4M | 89.5M | 191.6M | 131.7M | 63.8M | -108.5M | 244.9M |
| Other Non-Cash Items | 152M | -574.59M | -233.2M | 49.6M | 130.7M | 134.3M | -717.4M | 230.2M | 71.6M | 24M |
| Working Capital Changes | -214.86M | -22.99M | 97M | 151.7M | 628.9M | 372.1M | -243.3M | -218.3M | 261M | -1M |
| Cash from Investing | 264.29M | 725.62M | -541.2M | -2.2B | -619.8M | -735.2M | 157.6M | -262.1M | -637.7M | -657.8M |
| Capital Expenditures | -114.9M | -85.23M | -62.1M | -82.8M | -110.3M | -121.2M | -187.4M | -186.3M | -202.5M | -221.3M |
| Acquisitions | 33.06M | 810.68M | -129.1M | -1.05B | -7.6M | -531.9M | 1.3B | -67.7M | -300K | -17.9M |
| Purchase of Investments | -3.16B | -4.56B | -4.34B | -6.32B | -4.34B | -2.59B | -3.2B | -3.2B | -2.29B | -2.48B |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | 207.87M | 278.08M | -11.4M | -92.2M | -44M | 58.5M | -256.1M | -39.2M | -32.8M | -16.5M |
| Cash from Financing | -487.13M | -1.11B | -26.7M | 1.84B | -179.2M | -264.8M | -1.09B | -818.4M | -403.9M | -477.5M |
| Dividends Paid | -94.17M | -125.35M | -119M | -148M | -170M | -173.3M | -162.3M | -150.2M | -152.3M | -155.9M |
| Share Repurchases | -292.9M | -863.1M | -388.9M | -139.3M | -271.8M | -297M | -839.3M | -572.8M | -193.1M | -307.4M |
| Stock Issued | 0 | 0 | 0 | 276.4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 0 | -1000K | 1000K | 1000K | 1000K | 1000K | -1000K | -1000K | -1000K | 0 |
| Other Financing | -100.06M | 5.65M | 30.4M | 25M | 27.1M | -37M | 0 | -19.5M | -6.7M | -14.2M |
| Net Change in Cash | -30.35M | -256.33M | -35.2M | 257.2M | 613.1M | 361.5M | -173.8M | -518.1M | 90.7M | 180.3M |
| Exchange Rate Effect | -1000K | -1000K | 1000K | -1000K | -1000K | 1000K | -1000K | -1000K | -1000K | -1000K |
| Cash at Beginning | 1.32B | 1.29B | 1.03B | 996.8M | 1.25B | 1.87B | 2.23B | 2.05B | 1.54B | 1.63B |
| Cash at End | 1.29B | 1.03B | 996.8M | 1.25B | 1.87B | 2.23B | 2.05B | 1.54B | 1.63B | 1.81B |
| Free Cash Flow | 139.68M | 49.29M | 468.3M | 573.9M | 1.3B | 1.22B | 594.3M | 410.6M | 935.6M | 1.11B |
| FCF Growth % | -0.55% | -0.65% | 8.5% | 0.23% | 1.27% | -0.06% | -0.51% | -0.31% | 1.28% | 0.19% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | 2.02 | 0.8 | 8.47 | 9.64 | 20.91 | 19.32 | 9.88 | 7.5 | 17.4 | 21.14 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 98.17% | 94.02% | 92.96% | 95.83% | 95.23% | 93.98% | 92.43% | 96.57% | 92.75% | 92.19% |
| Medical Cost Ratio | 0% | 0% | 50.87% | 58.04% | 59% | 61.88% | 59.27% | 23.15% | 22.65% | 23.29% |
| Return on Equity (ROE) | 2.92% | 13.11% | 12.4% | 5.33% | 7.07% | 7.58% | 23.85% | 5.71% | 14.22% | 15.33% |
| Return on Assets (ROA) | 0.46% | 1.89% | 1.69% | 0.69% | 0.9% | 0.99% | 3.47% | 0.83% | 1.93% | 2.21% |
| Equity / Assets | 15.04% | 13.79% | 13.45% | 12.49% | 12.83% | 13.34% | 16.11% | 12.77% | 14.3% | 14.58% |
| Book Value / Share | 65.55 | 66.17 | 77.41 | 86.22 | 91.19 | 94.25 | 90.88 | 77.19 | 89.42 | 97.12 |
| Debt / Equity | 0.26x | 0.26x | 0.25x | 0.39x | 0.35x | 0.38x | 0.40x | 0.50x | 0.43x | 0.41x |
| Revenue Growth | -0.68% | -31.08% | -11.21% | 26.77% | 19.11% | 0.85% | 6% | 0.05% | 9.21% | 6.7% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Global Lifestyle | - | 3.82B | 3.51B | 5.37B | 7.34B | 7.53B | 7.95B | 6.83B | 7.36B | 9.32B |
| Global Lifestyle Growth | - | - | -8.08% | 53.03% | 36.71% | 2.54% | 5.54% | -14.08% | 7.80% | 26.64% |
| Global Housing | - | 2.36B | 2.25B | 2.17B | 2.13B | 2.05B | 2.08B | 1.87B | 2.01B | 2.58B |
| Global Housing Growth | - | - | -4.70% | -3.58% | -1.89% | -3.70% | 1.34% | -9.80% | 7.50% | 28.28% |
| Global Preneed | - | 431.03M | 443M | 467.5M | 486.2M | 491.4M | - | - | - | - |
| Global Preneed Growth | - | - | 2.78% | 5.53% | 4.00% | 1.07% | - | - | - | - |
| Solutions | 3.02B | - | - | - | - | - | - | - | - | - |
| Solutions Growth | - | - | - | - | - | - | - | - | - | - |
| Assurant Health | 2.22B | - | - | - | - | - | - | - | - | - |
| Assurant Health Growth | - | - | - | - | - | - | - | - | - | - |
| Specialty Property | 2.04B | - | - | - | - | - | - | - | - | - |
| Specialty Property Growth | - | - | - | - | - | - | - | - | - | - |
| Employee Benefits | 1.07B | - | - | - | - | - | - | - | - | - |
| Employee Benefits Growth | - | - | - | - | - | - | - | - | - | - |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | 8.92B | 6.24B | 4.98B | 6.22B | 7.88B | 8.03B | 8.32B | 8.39B | 9.3B | 9.82B |
| UNITED STATES Growth | - | -30.03% | -20.18% | 24.82% | 26.80% | 1.88% | 3.63% | 0.76% | 10.84% | 5.59% |
| Foreign Tax Authority | 1.41B | 1.29B | 1.43B | 1.84B | 2.2B | 2.06B | 1.86B | 1.81B | 1.84B | - |
| Foreign Tax Authority Growth | - | -8.21% | 11.00% | 28.34% | 19.72% | -6.36% | -9.65% | -3.11% | 1.63% | - |
Assurant, Inc. (AIZ) has a price-to-earnings (P/E) ratio of 16.4x. This is roughly in line with market averages.
Assurant, Inc. (AIZ) grew revenue by 6.7% over the past year. This is steady growth.
Yes, Assurant, Inc. (AIZ) is profitable, generating $848.8M in net income for fiscal year 2024 (6.4% net margin).
Yes, Assurant, Inc. (AIZ) pays a dividend with a yield of 1.25%. This makes it attractive for income-focused investors.
Assurant, Inc. (AIZ) has a return on equity (ROE) of 15.3%. This is reasonable for most industries.
Assurant, Inc. (AIZ) has a combined ratio of 92.2%. A ratio below 100% indicates underwriting profitability.